The NHS is set to trial a new breath test which uses artificial intelligence (AI) and operates at the ‘nanoparticles’ level to enable it to detect a range of diseases.
The new ‘electronic nose’ technology looks for chemicals, or ‘biomarkers’, that are produced by a number of conditions, including cancer, dementia and tuberculous (TB). The new breath test is more sensitive, meaning it will therefore be more accurate, than ones which are currently being used.
Please register or login to comment!
Register now Login